T1	Participants 45 75	X-linked retinitis pigmentosa:
T2	Participants 314 364	patients with X-linked retinitis pigmentosa (XLRP)
T3	Participants 686 750	Males (n = 78; 7-31 years) meeting entry criteria were enrolled.
T4	Participants 1735 1756	to patients with XLRP
